Neuroblastoma. Evaluation of 60 cases.
60 cases of neuroblastoma from the departments of paediatrics and paediatric surgery, Rigshospitalet, are reviewed. The overall cure rate was 35%. In localized disease (stages I--II) the prognosis was favourable (cure rate 78%), while the prognosis for disseminated disease (stages III--IV) was poor (cure rate 10.8%). Neuroblastomas in stage IV-S had a favourable prognosis in spite of metastases to the liver, skin and bone marrow. The clinical stage at the time of diagnosis was the only independent prognostic factor in this study.
D000367:Age Factors; D002675:Child, Preschool; D003718:Denmark; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007958:Leukocyte Count; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D010524:Peripheral Nervous System Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D011183:Postoperative Complications; D011379:Prognosis; D014642:Vanilmandelic Acid / Q000652:urine
D014642:Vanilmandelic Acid